X-Feed Billboard (International)

The newsboard processes news from the NASDAQ Nordic portfolio company GlobeNewswire, which provides investors with company-relevant information. This relates in particular to events that may be relevant to the listing of companies or tradable financial instruments.

GlobNewswire (formerly PrimeNewswire) specializes in public relations solutions and digital media services. This feed adds another important source of information for investors to the popular X-Billboard portfolio.

System-State: Number of processed items 43.829 Notifications successully processed since Inception
GlobeNewsWire ist eine wichtige Nachrichtenquelle, die über das X-Billboard abgerufen werden kann. Sie ist Teil des Newswire-Hub, der für Börsianer wichtige internationalen Nachrichtenquellen an einem zentralen Ort bündelt. Wer sich schnell einen Überblick verschaffen will, kann sich bequem durch die Headlines scrollen. Wer sich detailliert mit den Nachrichten auseinandersetzen möchte, kann über die Detailansichten der Info-Cards direkt auf die jeweilige Nachricht und weitere Analysewerkzeuge zugreifen.
NEWS
EXPLORER
US75943R1023
State: 27.12.2024 | 1AM
Do you already know our new terminal view? Click here.
FIGI: BBG00DSS08K9
RLAY

Relay Therapeutics, Inc.
GICS: - · Sector: Healthcare · Sub-Sector: Biotechnology
NAME
Relay Therapeutics, Inc.
ISIN
US75943R1023
TICKER
RLAY
MIC
XNAS
REUTERS
RLAY.OQ
BLOOMBERG
RLAY US
Wed, 11.12.2024       Relay Therapeutics

New interim data show 11.4-month median PFS in 2L patients with PI3Kα-mutated, HR+/HER2- metastatic breast cancer at RP2D

Mon, 09.12.2024       Relay Therapeutics

Company to host conference call on Wednesday, December 11, 2024 at 7am ET
Company to host conference call on Wednesday, December 11, 2024 at 7am ET
Tue, 03.12.2024       Relay Therapeutics

Global licensing agreement grants Elevar Therapeutics worldwide rights to develop and commercialize lirafugratinib (RLY-4008)

Wed, 11.09.2024       Relay Therapeutics

Relay Therapeutics Announces Pricing of Public Offering of Common Stock
Mon, 09.09.2024       Relay Therapeutics

Relay Therapeutics Announces Proposed Public Offering of Common Stock
Fri, 06.09.2024       Relay Therapeutics

Relay Therapeutics Announces Webcast to Report RLY-2608 Data on September 9, 2024
Thu, 06.06.2024       Relay Therapeutics

Relay Therapeutics Discloses Three New Programs at New Program & Platform Event
Wed, 05.06.2024       Relay Therapeutics

Initial triplet combination of RLY-2608 + atirmociclib + fulvestrant to be evaluated in patients with PI3Kα-mutated HR+/HER2- metastatic breast cancer; initiation planned by end of 2024
Initial triplet combination of RLY-2608 + atirmociclib + fulvestrant to be evaluated in patients with PI3Kα-mutated HR+/HER2- metastatic breast cancer; initiation planned by end of 2024
Thu, 02.05.2024       Relay Therapeutics

Relay Therapeutics Reports First Quarter 2024 Financial Results and Corporate Highlights

The information provided here is not subject to any editorial processing. It is prepared fully automatically and enriched with additional information and further research options. The aim of the content is to provide information seekers with the relevant information quickly and easily. A link back to the information provider and owner ensures that the data prepared here can be compared with the source information if required. The newsboard does not show information in real time. Please contact the exchange operator for this information if required. There is no claim to completeness. High availability cannot be guaranteed. If you notice any errors in the functionality, please let us know using the "Report a Bug" form below.

RAW DATA PROCESSING means that raw data is processed without changing the content. The data is supplemented to improve the interpretation of the information in terms of usability.

Note: The newswire cross-link panel at the top allows you to quickly and easily access additional sources of information. In the terminal view, the news is filtered at company level and enables targeted searches.


On behalf of the trading community, we would like to thank the operators of the trading venues for providing information services.